Tag: FDA biosimilarity

Biosimilar Approval: How FDA Reviews Biologic Alternatives in 2026

The FDA has overhauled its biosimilar approval process in 2025, cutting development time and costs by removing routine clinical trials. Learn how biosimilars are now approved faster, why they're safer than you think, and what's holding back wider use in the U.S.